Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 25;8(2):59-65.
doi: 10.2478/jtim-2020-0010. eCollection 2020 Jun.

COVID-19 and Tuberculosis

Heng Yang  1 , Shuihua Lu  1
Affiliations
Review

COVID-19 and Tuberculosis

Heng Yang et al. J Transl Int Med. .

Abstract

On March 11, 2020, the WHO declared that coronavirus disease 2019 (COVID-19) can be characterized as a pandemic based on the alarming levels of spread and severity and on the alarming levels of inaction. COVID-19 has received worldwide attention as emergency, endangering international public health and economic development. There is a growing body of literatures regarding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as well as COVID-19. This review will focus on the latest advance of epidemiology, pathogenesis, and clinical characteristics about COVID-19. Meanwhile, tuberculosis (TB) remains the leading representative respiratory tract communicable disease threatening public health. There are limited data on the risk of severe disease or outcomes in patients with concurrence of TB and COVID-19. Nevertheless, co-infection of some virus would aggravate TB, such as measles. And tuberculosis and influenza co-infection compared with tuberculosis single infection was associated with increased risk of death in individuals. This review will also introduce the characteristics about the concurrence of TB and emerging infectious diseases to provide a hint to manage current epidemic.

Keywords: COVID-19; SARS-CoV-2; clinical features; emerging infectious diseases; radiologic manifestation; tuberculosis.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest The authors have no conflicts of interest to disclose.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565–74. - PMC - PubMed
    1. WHO [Internet] Coronavirus disease 2019 (COVID-19) situation report - 140. 2020 Jun 08, 20; [cited 2020 June 09]. [about 17 screens]. Available from: https://ww.who.int/docs/default-source/coronaviruse/situation-reports/20... . Accessed on June 08, 2020.
    1. Liu W, Zhang Q, Chen J, Xiang R, Song H, Shu S. et al. Detection of Covid-19 in Children in Early January 2020 in Wuhan, China. New Engl J Med. 2020 Apr 2; - PMC - PubMed
    1. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Feb 24; - PubMed
    1. Nathavitharana RR, Friedland JS. A tale of two global emergencies: tuberculosis control efforts can learn from the Ebola outbreak. Eur Respir J. 2015;46:293–6. - PubMed

LinkOut - more resources